Literature DB >> 17376885

Surveillance for reassortant virus by multiplex reverse transcription-PCR specific for eight genomic segments of avian influenza A H5N1 viruses.

Prasert Auewarakul1, Kantima Sangsiriwut, Kridsda Chaichoune, Arunee Thitithanyanont, Witthawat Wiriyarat, Taweesak Songserm, Rasameepen Ponak-nguen, Jarunee Prasertsopon, Phisanu Pooruk, Pathom Sawanpanyalert, Parntep Ratanakorn, Pilaipan Puthavathana.   

Abstract

Avian influenza H5N1 virus is a global threat. An emergence of a reassortant virus with a pandemic potential is a major concern. Here we describe a multiplex reverse transcription-PCR assay that is specific for the eight genomic segments of the currently circulating H5N1 viruses to facilitate surveillance for a virus resulting from reassortment between human influenza virus and the H5N1 virus.

Entities:  

Mesh：

Year:  2007        PMID： 17376885      PMCID： PMC1865901          DOI： 10.1128/JCM.00382-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.

Authors:  Pilaipan Puthavathana; Prasert Auewarakul; Pakapak Chor Charoenying; Kantima Sangsiriwut; Phisanu Pooruk; Kobporn Boonnak; Raweewan Khanyok; Pranee Thawachsupa; Rungrueng Kijphati; Pathom Sawanpanyalert
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

4.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Authors:  K S Li; Y Guan; J Wang; G J D Smith; K M Xu; L Duan; A P Rahardjo; P Puthavathana; C Buranathai; T D Nguyen; A T S Estoepangestie; A Chaisingh; P Auewarakul; H T Long; N T H Hanh; R J Webby; L L M Poon; H Chen; K F Shortridge; K Y Yuen; R G Webster; J S M Peiris
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

5.  Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.

Authors:  Y Guan; J S M Peiris; A S Lipatov; T M Ellis; K C Dyrting; S Krauss; L J Zhang; R G Webster; K F Shortridge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205
  5 in total
  4 in total

1.  Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis.

Authors:  Jih-Hui Lin; Ching-Ping Tseng; Yen-Ju Chen; Chy-Yung Lin; Shy-Shin Chang; Ho-Sheng Wu; Ju-Chien Cheng
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

2.  SYBR green-based real-time reverse transcription-PCR for typing and subtyping of all hemagglutinin and neuraminidase genes of avian influenza viruses and comparison to standard serological subtyping tests.

Authors:  Kenji Tsukamoto; Carlos Javier Panei; Panei Carlos Javier; Makiko Shishido; Daigo Noguchi; John Pearce; Hyun-Mi Kang; Ok Mi Jeong; Youn-Jeong Lee; Koji Nakanishi; Takayoshi Ashizawa
Journal:  J Clin Microbiol       Date:  2011-10-26       Impact factor: 5.948

3.  Avian influenza virus (H5N1) in human, Laos.

Authors:  Pilaipan Puthavathana; Kantima Sangsiriwut; Achareeya Korkusol; Phisanu Pooruk; Prasert Auewarakul; Chakrarat Pittayawanganon; Derek Sutdan; Rungrueng Kitphati; Pathom Sawanpanyalert; Bounlay Phommasack; Khanthong Bounlu; Kumnuan Ungchusak
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

4.  Development and evaluation of a SYBR green-based real time RT-PCR assay for detection of the emerging avian influenza A (H7N9) virus.

Authors:  Zheng Zhu; Huan Fan; Xian Qi; Yuhua Qi; Zhiyang Shi; Hua Wang; Lunbiao Cui; Minghao Zhou
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.